Oxford Biomedica signs new deal to make AstraZeneca COVID shot Reuters Jul 4, 2022 Under the expanded deal, AstraZeneca will have access to Oxford Biomedica’s Oxbox manufacturing facility to produce its shot on an…
Serum Institute to invest $68 million in Oxford Biomedica Reuters Sep 23, 2021 As part of the deal, Serum Life Sciences, a unit of SII, will pick up a 3.9 per cent stake in Oxford Biomedica
